Prevalence of femoral nerve neurodynamic disorder in patients with patellofemoral pain syndrome: a cross-sectional study

髌股关节疼痛综合征患者股神经动力学障碍的患病率:一项横断面研究

阅读:1

Abstract

BACKGROUND: Patellofemoral pain syndrome (PFPS) is among the most prevalent causes of knee pain in young adults. Emerging evidence suggests that musculoskeletal pain syndromes, including PFPS, may be associated with neurodynamic disorders. The aim of this study was to investigate the prevalence of femoral nerve neurodynamic disorders in patients with PFPS and to examine the association between these disorders and various clinical and demographic variables, including age, sex, body mass index, pain intensity, history of low back pain, functional ability, and rectus femoris shortness. METHODS: In this cross-sectional study, one hundred patients with unilateral PFPS aged 18-44 years participated. The femoral slump test (FST) and the prone knee bending (PKB) test were employed to assess neurodynamic disorders of the femoral nerve. The associations between the results of neurodynamic tests and selected clinical and demographic variables were evaluated using logistic regression analysis. RESULTS: The prevalence of femoral nerve neurodynamic disorder in PFPS patients based on FST and PKB was 25% and 36% respectively. No significant associations were observed between FST results and the demographic or clinical variables of PFPS patients. In contrast, PKB results demonstrated significant associations with functional ability (OR = 0.96; 95% CI = 0.93-0.99), rectus femoris shortness (OR = 2.9; 95% CI = 1.15-7.33), and pain intensity (OR = 2.04; 95% CI = 1.36-3.07). CONCLUSION: More than one-quarter of PFPS patients exhibited increased mechanosensitivity of the femoral nerve, indicating a notable prevalence of neurodynamic disorders within this population. Nevertheless, the cross-sectional design and use of convenience sampling may limit the generalizability of these findings. These findings underscore the importance of incorporating neurodynamic assessments into the clinical evaluation of PFPS patients to facilitate more effective management.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。